More Biotech Growth Ahead – Boehringer Ingelheim Breaks Ground on Large Expansion
Kelly Kline
Economic Development Director & Chief Innovation Officer
Drug companies are expanding manufacturing in — where else? — the high-cost Bay Area.
A trio of international drug companies are wrapping up or moving forward on East Bay projects worth more than $400 million and some 300 new jobs.
Practically all the jobs will land in Fremont as German drug maker Boehringer Ingelheim expands its facility by a third. But buildouts by Germany-based Bayer HealthCare in Berkeley and Spain’s Grifols S.A. in Emeryville are no less significant, expanding on expertise already in the East Bay.
To read the full San Francisco Business Times article, visit https://www.bizjournals.com/sanfrancisco/news/2017/08/03/boehringer-ingelheim-bayer-grifols-grfs.html.
